Human Choroidal Melanocyte Signal Transduction Responses to Various Pharmacological Agents: Focus on Endothelin Receptors

REFERENCES

• Tayler HR, West S, Munoz B, et al. The long-term effects of visible light on the eye. Arch Ophthalmol. 1992;110:94–104.
   Google Scholar
• Cruickshanks KJ, Klein R, Klein BEK. Sunlight and age-related macular degeneration: The Beaver Dam Eye Study. Arch Ophthalmol. 1993;111:514–518.
   PubMed Web of Science ®Google Scholar
• Gallager RP, Elwood JM, Rootman J, et al. Risk factors for ocular melanoma: Western Canada melanoma study. J Nat Cancer Inst. 1985;74:775–778.
   Google Scholar
• Sarangarajan R, Apte SP. Review of melanization and phagocytosis: Implications for age related macular degeneration. Mol Vis. 2005;11:482–490.
   PubMed Web of Science ®Google Scholar
• Prassana G, Krishnamoorthy R, Yorio T. Endothelin, astrocytes and glaucoma. Exp Eye Res. (in press).
   Google Scholar
• Sharif NA, Whiting RL. Stimulation of inositol phosphate production in clonal HSDM1C1 cells by endothelins and sarafotoxin. Biochem Pharmacol. 1990;40:1928–1931.
   PubMedGoogle Scholar
• Narayan S, Brun AM, Yorio T. Endothelin-1 distribution and basolateral secretion in the retinal pigment epithelium. Exp Eye Res. 2004;79:11–19.
   Google Scholar
• Hu D-N. Regulation of growth and melanogenesis of uveal melanocytes. Pigment Cell Res. 2000;13(Suppl. 8):81–86.
   Google Scholar
• Hirose A, Azuma H, Tokoro T, et al. Endothelin-B receptors on suprachoroidal melanocytes mediate an endothelin-1-induced increase in the intracellular calcium concentration of rabbit ocular suprachoroidal tissue. Curr Eye Res. 2007;32:585–591.
   PubMed Web of Science ®Google Scholar
• Sharif NA, Crider JY. Intracellular signaling in human iridial fibroblasts and iridial melanocytes in response to prostaglandins, endothelin, isoprosterenol and other pharmacological agents. Curr Eye Res. (in press).
   Google Scholar
• Bito LZ. Prostaglandins: A new approach to glaucoma management with a new, intriguing side effect. Surv Ophthalmol. 1997;41(Suppl. 22):S1–S14.
   Google Scholar
• Wistrand PJ, Stjernschantz JW, Olsson K. The incidence and time-course of latanoprost-induced iridial pigmentation as a function of eye color. Surv Ophthalmol. 1997;41(Suppl. 2):S129–S138.
   Google Scholar
• Stjernschantz JW, Albert DM, Hu D-N, et al. Mechanism and clinical significance of prostaglandin-induced iris pigmentation. Surv Ophthalmol. 2002;47(Suppl. 1):S162–S175.
   Google Scholar
• Stjernschantz J, Selen G, Sjoquist B, et al. Preclinical pharmacology of latanoprost, a phenyl-substituted PGF2α analogue. Adv Prostaglandin Thrombox Leukotr Res. 1995;23:513–518.
   PubMedGoogle Scholar
• Hellberg MR, Sallee V, McLaughlin M, et al. Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist. J Ocular Pharmacol Ther. 2001;17:421–432.
   PubMed Web of Science ®Google Scholar
• Woodward DF, Krauss AHP, Chen J, et al. The pharmacology of bimatoprost (LumiganTM). Surv Ophthalmol. 2001;45(Suppl. 4):S337–S345.
   PubMedGoogle Scholar
• Taniguchi T, Haque MSR, Sugiyama K, et al. Ocular hypotensive mechanism of topical isopropyl unoprostone, a novel prostaglandin metabolite-related drug, in rabbit. J Ocular Pharmacol. 1996;12:489–498.
   Google Scholar
• Kang HY, Kang WH, Lee C. Endothelin-B receptor-mediated Ca2+ signaling in human melanocytes. Pflugers Arch. 1998;435:350–356.
   PubMedGoogle Scholar
• Shirasuna K, Watanabe S, Oki N, et al. A cooperative action of endothelin-1 with prostaglandin F2α on luteal function in the cow. Domest Animal Endocrinol. 2006;31:186–196.
   Google Scholar
• Hu D-N, Woodward WF, McCormick SA. Influence of autonomic neurotransmitters on human uveal melanocytes in vitro. Exp Eye Res. 2000;71:217–224.
   PubMed Web of Science ®Google Scholar
• Smith-Thomas L, Moustafa M, Spada CS, et al. Latanoprost-induced pigmentation in human iridial melanocytes is fibroblast dependent. Exp Eye Res. 2004;78:973–985.
   PubMed Web of Science ®Google Scholar
• Sharif NA, Xu SX, Williams GW, et al. Pharmacology of [3H]prostaglandin E1/[3H]prostaglandin E2 and [3H]prostaglandin F2α binding to EP3, and FP prostaglandin receptor binding sites in bovine corpus luteum: Characterization and correlation with functional data. J Pharmacol Exp Ther. 1998;286:1094–1102.
   PubMed Web of Science ®Google Scholar
• Eglen RM, Michel AD, Sharif NA, et al. Pharmacological properties of the peptide, endothelin. Br J Pharmacol. 1989;97:1297–1307.
   PubMedGoogle Scholar
• Crider JY, Williams GW, Drace CD, et al. Pharmacological characterization of a serotonin receptor (5HT7) stimulating cAMP production in human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2003;44:4837–4844.
   PubMed Web of Science ®Google Scholar
• Watts SW. Endothelin receptors: What’s new and what do we need to know? Am J Physiol Regula Integ Comp Physiol. 2010:298:R254–R260.
   Google Scholar
• Tyocki NR, Gariepy CE, Watts SW. Endothelin ETB receptors in arteries and veins: Multiple actions in veins. J Pharmacol Expt Ther. 2009;329:875–881.
   Google Scholar
• Okada M, Nishikibe M. BQ-788, a selective endothelin ET(B) receptor antagonist. Cardiovasc Drug Rev. 2002;20:53–66.
   Google Scholar
• Abdel-Latif AA, Yousufzai SYK, El-Mowafy AM, et al. Prostaglandins mediate the stimulatory effects of endothelin-1 on cyclic adenosine monophosphate accumulation in ciliary smooth muscle isolated from bovine, cat, and other mammalian species. Invest Ophthalmol Vis Sci. 1996;37:328–338.
   PubMedGoogle Scholar
• Takimoto M, Oda K, Sasaki Y, et al. Endothelin-1 receptor-mediated prostanoid secretion via autocrine and deoxyribonucleic acid synthesis via paracrine signaling in human bronchial epithelial cells. Endocrinol. 1996;137:4542–4550.
   PubMedGoogle Scholar
• Miceli F, Minicin F, Garcia P, et al. Endothelins enhance prostaglandin (PGE2 and PGF2α) biosynthesis and release by human luteal cells: Evidence of a new paracrine/autocrine regulation of luteal function. J Clin Endocrinol Metab. 2001;86:811–817.
   PubMedGoogle Scholar
• Toda A, Suzuki I, Im S, et al. Endothelin-1 is a paracrine growth factor that modulates melanogenesis and participates in their responses to ultraviolet radiation. Cell Growth Diff. 1998;9:575–584.
   PubMedGoogle Scholar
• Imokawa G. Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders. Pigment Cell Res. 2004;17:96–110.
   PubMedGoogle Scholar
• Imokawa G, Yada Y, Kimura M. Signaling mechanisms of endothelin-induced mitogenesis and melanogenesis in human melanocytes. Biochem J. 1996;314:305–312.
   PubMedGoogle Scholar
• Imokawa G, Miyagishi M, Yada Y. Endothelin-1 as a new melanogen: Coordinated expression of its gene and tyrosinase gene in UVB-exposed human epidermis. J Invest Dermatol. 1995;105:32–37.
   PubMed Web of Science ®Google Scholar
• Crider JY, Sharif NA. Functional pharmacological evidence for EP2 and EP4 prostanoid receptors in immortalized human trabecular meshwork and non-pigmented ciliary epithelial cells. J Ocular Pharmacol Ther. 2001;17:35–46.
   PubMed Web of Science ®Google Scholar